Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

KalVista Pharmaceuticals Q1 EPS $(0.66) Down From $(0.61) YoY

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.66) per share. This is a 8.2 percent decrease over losses of $(0.61) per share from the same period last year.
byBenzinga Newsdesk
September 9, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

KalVista Pharmaceuticals (NASDAQ:KALV) reported quarterly losses of $(0.66) per share. This is a 8.2 percent decrease over losses of $(0.61) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts